1. Home
  2. Approved trials
  3. » فارسی

Comprrison of Effectiveness of Attempted Suicide Short Intervention Program (ASSIP) on Suicidal Ideation, Reasons for Living, Coping Styles, Help Seeking Intention and Prevention of Suicide Attempt between Women and Men Suicide Attempters

Protocol summary

Study aim
Comprrison of Effectiveness of Attempted Suicide Short Intervention Program (ASSIP) on Suicidal Ideation, Reasons for Living, Coping Styles, Help Seeking Intention and Prevention of Suicide Attempt between Women and Men Suicide Attempters.
Design
a true experimental design with a pretest–posttest format and five follow-up stages at weeks 1, 2, 4, 8, and 12, including TAU group.
Settings and conduct
psychology and counselling centers at Ahvaz; Jundishapur of Medical Science Centers of Ahvaz
Participants/Inclusion and exclusion criteria
Inclusion criteria: at least 1 suicide attempt during the last four months Age 20-40 years seccond primary school & able to read and write) Signing the informed consent form No serious medical or psychiatric conditions requiring special treatment (schizophrenia spectrum and dependency) No diagnosis of personality disorders Exclusion criteria: Non-cooperation in completing the questionnaires Not consenting to video/audio recording Absence from one ASSIP sessions (except the 4 session) Receiving concurrent psychotherapy
Intervention groups
Exprimental Groups: The experimental group refers to the group on which ASSIP as the independent variable, is applied. ASSIP is a brief intervention consisting of 3 to 4 sessions designed to prevent suicide attempts. Control groups (TAU): While the experimental groups receive ASSIP, the TAU groups do not receive ASSIP or any structured psychotherapy. However, they may receive usual care.
Main outcome variables
1. Suicidal ideation by BSSI 2. Reasons for living by RFL 3. Coping styles by CISS 4. Help-seeking intention by GHSQ 5. Suicide attempt prevention by SSF-3; and in-person/telephone interviews

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20160716028953N2
Registration date: 2025-08-30, 1404/06/08
Registration timing: retrospective

Last update: 2025-08-30, 1404/06/08
Update count: 0
Registration date
2025-08-30, 1404/06/08
Registrant information
Name
Abdolazim Shahroie
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 916 973 8355
Email address
azim.shahroiee@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-12-30, 1403/10/10
Expected recruitment end date
2025-02-19, 1403/12/01
Actual recruitment start date
2024-12-30, 1403/10/10
Actual recruitment end date
2025-02-19, 1403/12/01
Trial completion date
2025-02-19, 1403/12/01
Scientific title
Comprrison of Effectiveness of Attempted Suicide Short Intervention Program (ASSIP) on Suicidal Ideation, Reasons for Living, Coping Styles, Help Seeking Intention and Prevention of Suicide Attempt between Women and Men Suicide Attempters
Public title
Studying the effect of a short-term suicide prevention program on suicidal thoughts, reasons for living, coping styles, and help-seeking intention in women and men with a history of suicide attempt
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Having a history of at least one suicide attempt during the last four months Age range between 20-40 years Being literate (at least completed second grade of primary school and able to read and write) Signing the informed consent form No serious medical or psychiatric conditions requiring special treatment (NO current substance or alcohol dependence, No current schizophrenia or psychotic disorders) No diagnosis of personality disorders
Exclusion criteria:
Having a psychotic disorder Having a serious personality disorder Active drug/alcohol use or dependence disorders Inability to understand and comprehend questionnaires (insufficient literacy or serious cognitive problems) Language problem (inability to speak or understand Persian) Undergoing other regular psychotherapy at the same time Acute medical or psychiatric condition that prevents attendance at sessions Failure to complete a consent form to participate in the study
Age
From 20 years old to 40 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size: 52
More than 1 sample in each individual
Number of samples in each individual: 7
Participants complete the questionnaires and semi-structured interviews during one pretest, one posttest, and five follow-up stages, resulting in a total of seven assessment points.
Actual sample size reached: 44
More than 1 sample in each individual
Actual sample size in each individual: 7
Each participant completed assessments at 7 time points, including one pre-test, one post-test, and five follow-up stages using questionnaires and semi-structured interviews.
Randomization (investigator's opinion)
Randomized
Randomization description
After selecting 52 eligible participants, the allocation of individuals to 4 groups will be done by simple random method. The random sequence will be done by an independent person using a random number table ( SPSS/Random Allocation software). Then, based on this sequence, the participants will be equally placed into 4 groups (female experimental, female control, male experimental, male control) groups. To conceal allocation, the sequencing results will be placed in opaque, sealed envelopes and opened in the order in which participants arrive.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Faculty of Medicine-Shahed University
Street address
Shahed University, opposite Holy shrine of Imam Khomeini, Khalij Fars Expressway, Tehran, Iran
City
Tehran
Province
Khouzestan
Postal code
3319118651
Approval date
2025-07-14, 1404/04/23
Ethics committee reference number
IR.SHAHED.MED.REC.1404.026

Health conditions studied

1

Description of health condition studied
suicide attempt
ICD-10 code
T14.91
ICD-10 code description
Suicide attempt

Primary outcomes

1

Description
suicide ideation: Suicidal ideation or thoughts are defined as thinking about, considering, or planning to commit suicide (Klonsky et al., 2016).
Timepoint
1- Pre-test (before intervention/without intervention); 2- Post-test (after intervention and 1 month after pre-test); 3- First follow-up (1 week after post-test); 4- Second follow-up (2 weeks after post-test); 5- Third follow-up (4 weeks after post-test); 6- Fourth follow-up (8 weeks after post-test); 7- Fifth follow-up (12 weeks after post-test)
Method of measurement
Beck Scale for Suicide Ideation (BSSI) - Beck

2

Description
reasons for living: Reasons for living (RFL) are beliefs or expectations that are thought to reduce the risk of suicide and include survival and coping beliefs, responsibility to family, concerns about children, fear of suicide, fear of social disapproval, and moral objections (Linehan et al., 1983).
Timepoint
1- Pre-test (before intervention/without intervention); 2- Post-test (after intervention and 1 month after pre-test); 3- First follow-up (1 week after post-test); 4- Second follow-up (2 weeks after post-test); 5- Third follow-up (4 weeks after post-test); 6- Fourth follow-up (8 weeks after post-test); 7- Fifth follow-up (12 weeks after post-test)
Method of measurement
Reasons for Living Scale (RFL) - Linehan

3

Description
coping styles: A coping style or strategy is an action, set of actions, or thought process used to deal with a stressful or unpleasant situation or to modify a person's response to such a situation. Unlike defense mechanisms, coping strategies usually involve a conscious and direct approach to problems (Dictionary of the American Psychological Association 2023).
Timepoint
1- Pre-test (before intervention/without intervention); 2- Post-test (after intervention and 1 month after pre-test); 3- First follow-up (1 week after post-test); 4- Second follow-up (2 weeks after post-test); 5- Third follow-up (4 weeks after post-test); 6- Fourth follow-up (8 weeks after post-test); 7- Fifth follow-up (12 weeks after post-test)
Method of measurement
Coping Inventory for Stressful Situation (CISS) - Endler & Parker

4

Description
help seeking intention: Help-seeking intention is defined as an individual's subjective possibility of seeking help (Wei, 2017).
Timepoint
1- Pre-test (before intervention/without intervention); 2- Post-test (after intervention and 1 month after pre-test); 3- First follow-up (1 week after post-test); 4- Second follow-up (2 weeks after post-test); 5- Third follow-up (4 weeks after post-test); 6- Fourth follow-up (8 weeks after post-test); 7- Fifth follow-up (12 weeks after post-test)
Method of measurement
General Help Seeking Questionnaire (GHSQ) - Wilson et al

5

Description
prevention of suicide attempt: Suicide prevention is a set of efforts to reduce the risk of suicide (Centers for Disease Control, 2019).
Timepoint
1- Pre-test (before intervention/without intervention); 2- Post-test (after intervention and 1 month after pre-test); 3- First follow-up (1 week after post-test); 4- Second follow-up (2 weeks after post-test); 5- Third follow-up (4 weeks after post-test); 6- Fourth follow-up (8 weeks after post-test); 7- Fifth follow-up (12 weeks after post-test)
Method of measurement
Inperson/Telephone Interview; Suicide Status Form (SSF-3) - Jobes

Secondary outcomes

empty

Intervention groups

1

Description
1. Women experimental Group (ASSIP): Female suicide attempters who receive the ASSIP intervention. ASSIP (Attempted Suicide Short Intervention Program) is an ultra-brief psychotherapy consisting of 3 to 4 weekly face-to-face sessions, each lasting 60 to 90 minutes, conducted over the course of approximately one month. The intervention follows a narrative-based therapeutic approach and is delivered by a trained clinician. Session 1 involves video or audio recording of the participant’s personal narrative, focusing on the background, crisis experience, and suicidal behavior. In Session 2, the participant and therapist review the recorded material together, engaging in a collaborative reflection and dual processing of the narrative to gain insight. Session 3 focuses on the development of an individualized safety plan, identifying personal warning signs and adaptive coping strategies, with the guidance of the therapist. Session 4 includes a review of key insights, consolidation of safety strategies and coping mechanisms, and preparation for ongoing support through continued therapeutic contact.
Category
Behavior

2

Description
2. Men experimental Group (ASSIP): Male suicide attempters who receive the ASSIP intervention. ASSIP (Attempted Suicide Short Intervention Program) is an ultra-brief psychotherapy consisting of 3 to 4 weekly face-to-face sessions, each lasting 60 to 90 minutes, conducted over the course of approximately one month. The intervention follows a narrative-based therapeutic approach and is delivered by a trained clinician. Session 1 involves video or audio recording of the participant’s personal narrative, focusing on the background, crisis experience, and suicidal behavior. In Session 2, the participant and therapist review the recorded material together, engaging in a collaborative reflection and dual processing of the narrative to gain insight. Session 3 focuses on the development of an individualized safety plan, identifying personal warning signs and adaptive coping strategies, with the guidance of the therapist. Session 4 includes a review of key insights, consolidation of safety strategies and coping mechanisms, and preparation for ongoing support through continued therapeutic contact.
Category
Behavior

3

Description
3- Women Control Group (TAU): Women in this group will receive the standard care typically provided for suicide attempters in the selected clinical setting. TAU may include psychiatric evaluation, pharmacotherapy, crisis intervention, or referral to outpatient mental health services, as deemed appropriate by clinical staff. No ASSIP sessions and other standard psychotherapies will be provided.
Category
Treatment - Drugs

4

Description
4- Men Control Group (TAU): Men in this group will receive the standard care typically provided for suicide attempters in the selected clinical setting. TAU may include psychiatric evaluation, pharmacotherapy, crisis intervention, or referral to outpatient mental health services, as deemed appropriate by clinical staff. No ASSIP sessions and other standard psychotherapies will be provided.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Zehne Bartar Psychology & Counseling Center
Full name of responsible person
Mehran Shahroie
Street address
Iran, Ahvaz, Naderi, Hafez St., Khatam Al-Anbia Medical Complex, 4th Floor
City
Ahvaz
Province
Khouzestan
Postal code
6195668933
Phone
+98 901 503 8792
Email
zehnebartar.psychology@gmail.com

2

Recruitment center
Name of recruitment center
Psychology & Counseling Clinic of Abdolazim Shahroie
Full name of responsible person
Abdolazim Shahroie
Street address
Iran, Ahvaz, Naderi, Hafez St., Khatam Al-Anbia Medical Complex, 5th Floor
City
Ahvaz
Province
Khouzestan
Postal code
6195668933
Phone
+98 916 973 8355
Email
azim.shahroiee@yahoo.com

3

Recruitment center
Name of recruitment center
Jundishapur University of Medical Science: Golestan Hospital
Full name of responsible person
Hatam Boostani
Street address
Iran, Ahvaz, Golestan, Farvardin st., Golestan Hospital
City
Ahvaz
Province
Khouzestan
Postal code
3311761357
Phone
+98 61 3320 4501
Email
boostani.h@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahed University
Full name of responsible person
Shahriar Bijani
Street address
Shahed University, opposite Holy shrine of Imam Khomeini, Khalij Fars Expressway, Tehran, Iran
City
Ahvaz
Province
Khouzestan
Postal code
3319118651
Phone
+98 21 5522 8800
Email
humres@shahed.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahed University
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahed University
Full name of responsible person
Abdolazim Shahroie
Position
Ph.D student
Latest degree
Master
Other areas of specialty/work
Psychology
Street address
Iran, Ahvaz, Shahrak Bargh, Manazele Shahrdari, Street 10, appartment 11, Unit 1
City
Ahvaz
Province
Khouzestan
Postal code
6137896473
Phone
‎+‎986132234716
Fax
Email
azim.shahroiee@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahed University
Full name of responsible person
Abdolazim Shahroie
Position
Ph.D student
Latest degree
Master
Other areas of specialty/work
Psychology
Street address
Iran, Ahvaz, Bargh Town, Manazel Shahrdari, 10th Street, Block 11, Unit 1
City
Ahvaz
Province
Khouzestan
Postal code
6137896473
Phone
+‎986132234716
Email
azim.shahroiee@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Shahed University
Full name of responsible person
Abdolazim Shahroie
Position
Ph.D student
Latest degree
Master
Other areas of specialty/work
Psychology
Street address
Iran, Ahvaz, Bargh Town, Manazel Shahrdari, 10th Street, Block 11, Unit 1
City
Ahvaz
Province
Khouzestan
Postal code
6137896473
Phone
+‎986132234716
Email
azim.shahroiee@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
Yes – De-identified individual participant data (IPD), including demographic data, primary and secondary outcome measures, and relevant statistical data, will be shared upon reasonable request. Data will be available after publication of the main results. Researchers interested in accessing the data must submit a methodologically sound research proposal and obtain approval from the principal investigator. Data will be shared via secure electronic platforms while ensuring confidentiality.
When the data will become available and for how long
Access to de-identified participant data (including demographic information, primary and secondary outcomes, and relevant statistical data) will begin 6 months after publication of the main results and will remain available for a period of 5 years.
To whom data/document is available
Access will be granted to qualified researchers from academic institutions, research centers, and industry who submit a methodologically sound research proposal. All requests must be approved by the principal investigator.
Under which criteria data/document could be used
The data and related documents may only be used for scientific and research purposes; any commercial or unauthorized use is strictly prohibited. Use of the data must align with an approved research proposal and comply with ethical research standards. Permitted analyses include secondary statistical analyses and meta-analyses that contribute to scientific knowledge. Applicants must submit a formal request including a methodologically sound research proposal, an official request letter, and a confidentiality agreement. All requests will be reviewed and approved by the principal investigator before data access is granted.
From where data/document is obtainable
Requests for data or documents should be directed to the Principal Investigator. Email is the preferred method of contact. Contact information is as follows: Abdolazim Shahroie azim.shahroiee@yahoo.com
What processes are involved for a request to access data/document
Requests for data or documents follow a structured process as outlined below: 1. Submit a formal request via email to the Principal Investigator, including: A methodologically sound research proposal; An official request letter; A signed confidentiality agreement. 2. Review of the request by the research team for scientific, ethical, and technical suitability (within 2 to 4 weeks). 3. Notification of decision and, if approved, preparation of a Data Access Agreement. 4. Transfer of approved data/documents via secure and encrypted platforms after signing the agreement. In total, depending on the completeness of the submitted documents, the process typically takes 3 to 6 weeks.
Comments
Loading...